Lentiviral Vector-mediated Gene Transfer in Human Bladder Cancer Cell Lines

被引：8

作者：

Matsunaga, Wataru ^{[1
]}

Ichikawa, Misa ^{[1
,2
]}

Nakamura, Azumi ^{[1
]}

Ishikawa, Takahiro ^{[1
,2
]}

Gotoh, Akinobu ^{[1
]}

机构：

[1] Hyogo Coll Med, Inst Adv Med Sci, Lab Cell & Gene Therapy, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan

[2] Sentan Bio Med Lab, Tokyo, Japan

来源：

ANTICANCER RESEARCH | 2018年 / 38卷 / 04期

关键词：

Lentivirus; p53; p16; PTEN; bladder cancer; TUMOR-SUPPRESSOR GENE; IN-VIVO; PROSTATE-CANCER; RISK-FACTORS; PTEN GENE; P53; GENE; THERAPY; EXPRESSION; MUTATIONS; PATHWAY;

D O I：

10.21873/anticanres.12440

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background/Aim: Currently, treatment of non-muscle invasive bladder cancer causes significant deterioration in a patient's quality of life (QOL). Therefore, development of novel therapeutic options without the deterioration of QOL is very important. In this study, we assessed the anti-tumor effect of lentivirus-mediated gene transfection of tumor-suppressor genes in human bladder cancer cells. Materials and Methods: Lentiviral vectors that contained the tumor suppressor genes, p53, p16, and PTEN, were transfected into human bladder cancer cell lines, 5637, T24, 253J, and UMUC3, and the normal human uroepithelial cell line, SV-HUC-1. Results: Significant growth inhibition was observed in bladder cancer cells on transfection with the p16 and PTEN vectors. However, the effect of the p53 vector was limited. In normal cells, the lentiviral vectors did not exhibit a significant growth inhibitory effect. Conclusion: Lentiviral vector-mediated gene transfection is useful for the application of gene therapy in bladder cancers.

引用

页码：2015 / 2020

页数：6

共 50 条

[41] Vector-mediated gene transfer into rhesus macaque embryos
不详
[J]. REPRODUCTION FERTILITY AND DEVELOPMENT, 2006, 18 (1-2) : 295 - 295
[42] Adenovirus vector-mediated gene transfer into stem cells
Kawabata, Kenji
Sakurai, Funlinori
Koizumi, Naoya
Hayakawa, Takao
Mizuguchi, Hiroyuki
[J]. MOLECULAR PHARMACEUTICS, 2006, 3 (02) : 95 - 103
[43] Vector-Mediated Antibody Gene Transfer for Infectious Diseases
Schnepp, Bruce C.
Johnson, Philip R.
[J]. GENE THERAPY FOR HIV AND CHRONIC INFECTIONS, 2015, 848 : 149 - 167
[44] RETROVIRAL VECTOR-MEDIATED GENE-TRANSFER INTO HUMAN HEMATOPOIETIC PROGENITOR CELLS
GRUBER, HE
FINLEY, KD
HERSHBERG, RM
KATZMAN, SS
LAIKIND, PK
SEEGMILLER, JE
FRIEDMANN, T
YEE, JK
JOLLY, DJ
[J]. SCIENCE, 1985, 230 (4729) : 1057 - 1061
[45] Viral vector-mediated gene transfer for CNS disease
Snyder, Brooke R.
Boulis, Nicholas M.
Federici, Thais
[J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (03) : 381 - 394
[46] Lentiviral vector-mediated gene therapy for a mouse model of spinal muscular atrophy
Azzouz, M
Le, TN
Waddington, S
Walmsley, L
Monani, U
Wilkes, FJ
Themis, M
Mitrophanous, KA
Burghes, A
Mazarakis, ND
[J]. MOLECULAR THERAPY, 2003, 7 (05) : S248 - S248
[47] Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy
Capowski, Elizabeth E.
Schneider, Bernard L.
Ebert, Allison D.
Seehus, Corey R.
Szulc, Jolanta
Zufferey, Romain
Aebischer, Patrick
Svendsen, Clive N.
[J]. JOURNAL OF NEUROSCIENCE METHODS, 2007, 163 (02) : 338 - 349
[48] Lentiviral Vector-Mediated CFTR Gene Transfer to CF Pig Airways Corrects the Anion Transport Defect In Vivo
Cooney, Ashley L.
Abou Alaiwa, Mahmoud H.
Stoltz, David A.
Welsh, Michael J.
Sinn, Patrick L.
McCray, Paul B.
[J]. MOLECULAR THERAPY, 2015, 23 : S3 - S3
[49] High-efficiency lentiviral vector-mediated gene transfer into murine macrophages and activated splenic B lymphocytes
Rossi, GR
Mautino, MR
Morgan, RA
[J]. HUMAN GENE THERAPY, 2003, 14 (04) : 385 - 391
[50] Characterization of the Properties of Seven Promoters in the Motor Cortex of Rats and Monkeys After Lentiviral Vector-Mediated Gene Transfer
Yaguchi, Masae
Ohashi, Yohei
Tsubota, Tadashi
Sato, Ayana
Koyano, Kenji W.
Wang, Ningqun
Miyashita, Yasushi
[J]. HUMAN GENE THERAPY METHODS, 2013, 24 (06) : 333 - 344

← 1 2 3 4 5 →